Why ATAI? AtaiBeckley Inc. Analysis, Price & AI Insights | Whystock
ATAI
$4.14-0.02 (-0.48%)
Market ClosedLast close May 1
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.